Search

everythinglearnresearchcommunity

for

Search:↓

Ethanol withdrawal reduces the brain's response to certain calming steroids, making seizures harder to control.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

The YH complex, made from certain plant extracts, effectively promotes hair regrowth and could be a potential treatment for hair loss.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Baricitinib is effective and safe for treating severe alopecia areata.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Cholecystokinin may help reduce skin inflammation in psoriasis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Baricitinib may effectively treat nail changes in alopecia areata.

Newly made nicotinamide compounds could potentially treat cancer.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.